Search Results

There are 12292 results for: content related to: Dopamine agonist use and the risk of heart failure

  1. Levodopa does not change cerebral vasoreactivity in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 4, April 2013, Pages: 469–475, Alexandre Krainik, Audrey Maillet, Vanessa Fleury, Mehmet Sahin, Irène Troprès, Laurent Lamalle, Stephane Thobois, Valerie Fraix, Marjorie Villien, Jan Warnking, Pierre Pollak, Serge Pinto and Paul Krack

    Article first published online : 12 DEC 2012, DOI: 10.1002/mds.25267

  2. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 161–169, Philip Prah, Irene Petersen, Irwin Nazareth, Kate Walters and David Osborn

    Article first published online : 19 AUG 2011, DOI: 10.1002/pds.2213

  3. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 442–449, Tim A. Bruckner, Ashley Hodgson, Chris Brown Mahoney, Brent D. Fulton, Peter Levine and Richard M. Scheffler

    Article first published online : 24 OCT 2011, DOI: 10.1002/pds.2264

  4. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1168–1176, Susan E. Andrade, Tiffany A. Moore Simas, Denise Boudreau, Marsha A. Raebel, Sengwee Toh, Beth Syat, Inna Dashevsky and Richard Platt

    Article first published online : 22 AUG 2011, DOI: 10.1002/pds.2217

  5. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1064–1072, Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg and Anke-Hilse Maitland-van der Zee

    Article first published online : 24 AUG 2011, DOI: 10.1002/pds.2228

  6. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 911–919, Maria Sjölander, Marie Eriksson and Eva-Lotta Glader

    Article first published online : 8 NOV 2011, DOI: 10.1002/pds.2268

  7. Hospitalised ischaemic cerebrovascular accident and risk factors in a primary care database

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1050–1056, Elisa Martín-Merino, Ana Ruigomez, Saga Johansson and Luis-Alberto García-Rodríguez

    Article first published online : 8 AUG 2011, DOI: 10.1002/pds.2201

  8. Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 407–414, Catherine Corbell, Ishmael Katjitae, Assegid Mengistu, Francis Kalemeera, Evans Sagwa, David Mabirizi, Jennie Lates, Jude Nwokike, Sherrilyne Fuller and Andy Stergachis

    Article first published online : 18 OCT 2011, DOI: 10.1002/pds.2252

  9. Impact of exposure accrual on sequential postmarket evaluations: a simulation study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1184–1191, Judith C. Maro and Jeffrey S. Brown

    Article first published online : 24 AUG 2011, DOI: 10.1002/pds.2223

  10. Record linkage for pharmacoepidemiological studies in cancer patients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 94–103, Myrthe P. P. van Herk-Sukel, Valery E. P. P. Lemmens, Lonneke V. van de Poll-Franse, Ron M. C. Herings and Jan Willem W. Coebergh

    Article first published online : 2 AUG 2011, DOI: 10.1002/pds.2205

  11. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 7, July 2012, Pages: 697–709, Jeremy A. Rassen, Robert J. Glynn, Kenneth J. Rothman, Soko Setoguchi and Sebastian Schneeweiss

    Article first published online : 8 DEC 2011, DOI: 10.1002/pds.2256

  12. Stroke risk and NSAIDs: a systematic review of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1225–1236, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Antoine Pariente, Lorenza Scotti, Miriam Sturkenboom and Susana Perez-Gutthann

    Article first published online : 3 OCT 2011, DOI: 10.1002/pds.2227

  13. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  14. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1130–1137, Rolf H. H. Groenwold, Frank de Vries, Anthonius de Boer, Wiebe R. Pestman, Frans H. Rutten, Arno W. Hoes and Olaf H. Klungel

    Article first published online : 23 SEP 2011, DOI: 10.1002/pds.2251

  15. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 920–928, Emily S. Brouwer, Suzanne L. West, Marianne Kluckman, Dennis Wallace, Andrew L. Masica, Edward Ewen, Rustam Kudyakov, Dunlei Cheng, James Bowen and Neil S. Fleming

    Article first published online : 16 JAN 2012, DOI: 10.1002/pds.2262

  16. Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1045–1052, Øystein Karlstad, Per Nafstad, Aage Tverdal, Svetlana Skurtveit and Kari Furu

    Article first published online : 23 SEP 2011, DOI: 10.1002/pds.2233

  17. Risk of cancer in patients exposed to gabapentin in two electronic medical record systems

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 214–225, Michael C. Irizarry, David J. Webb, Nada Boudiaf, John Logie, Laurel A. Habel, Natalia Udaltsova and Gary D. Friedman

    Article first published online : 6 DEC 2011, DOI: 10.1002/pds.2266

  18. Major bleeding risk associated with warfarin and co-medications in the elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1057–1063, Agnes I. Vitry, Elizabeth E. Roughead, Emmae N. Ramsay, Adrian K. Preiss, Philip Ryan, Andrew L. Gilbert, Gillian E. Caughey, Sepehr Shakib, Adrian Esterman, Ying Zhang and Robyn A McDermott

    Article first published online : 17 AUG 2011, DOI: 10.1002/pds.2219

  19. Antipsychotic drugs and risk of pulmonary embolism

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 42–48, Benoit Allenet, Sophie Schmidlin, Céline Genty and Jean-Luc Bosson

    Article first published online : 4 NOV 2011, DOI: 10.1002/pds.2210

  20. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 929–936, Kjell H. Halvorsen, Anne Gerd Granas, Anders Engeland and Sabine Ruths

    Article first published online : 13 SEP 2011, DOI: 10.1002/pds.2232